Orbimed Advisors LLC Burning Rock Biotech LTD Transaction History

Orbimed Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.39 - $3.96 $255,696 - $423,664	-106,986 Reduced 7.7%	1,282,816 $3.07 Million
Q2 2022 Aug 15, 2022	SELL	$1.75 - $10.44 $109,550 - $653,544	-62,600 Reduced 4.31%	1,389,802 $4.04 Million
Q4 2021 Feb 14, 2022	SELL	$9.43 - $17.14 $3.81 Million - $6.92 Million	-403,799 Reduced 21.75%	1,452,402 $13.8 Million
Q2 2021 Aug 16, 2021	SELL	$26.14 - $37.45 $1.08 Million - $1.55 Million	-41,462 Reduced 2.18%	1,856,201 $54.7 Million
Q1 2021 May 17, 2021	SELL	$23.5 - $39.58 $53.2 Million - $89.6 Million	-2,264,012 Reduced 54.4%	1,897,663 $51.1 Million
Q4 2020 Feb 16, 2021	SELL	$22.55 - $30.87 $13.2 Million - $18 Million	-584,400 Reduced 12.31%	4,161,675 $96.1 Million
Q3 2020 Nov 16, 2020	BUY	$19.07 - $29.61 $76 - $118	4 Added 0.0%	4,746,075 $119 Million
Q2 2020 Aug 14, 2020	BUY	$23.21 - $31.43 $110 Million - $149 Million	4,746,071 New	4,746,071 $128 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $705M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.